Disease prevention trials in IBD: feasibility to future outlook

Nat Rev Gastroenterol Hepatol. 2025 Jan;22(1):1-2. doi: 10.1038/s41575-024-00984-3.

Sailish Honap^{1

2

3}, Nelly Agrinier^{4

5}, Silvio Danese⁶, Laurent Peyrin-Biroulet⁷

¹ Department of Gastroenterology, INFINY Institute, Inserm NGERE, CHRU Nancy, Nancy, France.
² Department of Gastroenterology, St George's University Hospitals NHS Foundation Trust, London, UK.
³ School of Immunology and Microbial Sciences, King's College London, London, UK.
⁴ CIC, Epidémiologie Clinique, Université de Lorraine, CHRU Nancy, Inserm, Nancy, France.
⁵ INSPIIRE, Université de Lorraine, Inserm, Nancy, France.
⁶ Department of Gastroenterology and Endoscopy, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.
⁷ Department of Gastroenterology, INFINY Institute, Inserm NGERE, CHRU Nancy, Nancy, France. [email protected].

No abstract available